In 2022, 23 273 cases of hepatitis C were reported in 29 EU/EEA countries. Excluding countries that only reported acute cases, 23 249 cases were notified, corresponding to a crude rate of 6.2 cases per 100 000 population.
Recent ECDC data show that despite progress in prevention and control efforts, the hepatitis B and hepatitis C viruses (HBV and HCV) continue to pose significant public health challenges in the European Union and European Economic Area (EU/EEA).
The annual European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) is taking place in Stockholm and online from 20-22 November 2024.
This annual meeting of National ECDC Correspondents focused on the technical cooperation developments over the last year in the areas of disease surveillance, microbiology, preparedness and response.